Chromadex

WATCH: China’s rising awareness on NAD+ an opportunity – Chromadex CEO on Sinopharm Xingsha deal

18-Oct-2021 By Tingmin Koe

China’s consumers are increasingly aware of how nicotinamide adenine dinucleotide (NAD+) plays a role in health, and Chromadex believes this presents opportunities for its flagship product Tru Niagen.

From ageing to active nutrition: ChromaDex expands TRU NIAGEN range to address active lifestyle needs in Hong Kong

23-Nov-2020 By Tingmin Koe

ChromaDex has launched its nicotinamide riboside (NR) supplement, TRU NIAGEN, in stick packs in Hong Kong as it seeks to cater to the nutritional needs of active individuals, beyond its traditional healthy ageing customer base.

Looking good: Chromadex debuts in beauty-from-within category with HK launch

04-May-2020 By Tingmin Koe

Chromadex, the nicotinamide riboside (NR) specialist, has entered the beauty-from-within space with its new product exclusively launched in A.S. Watsons Hong Kong both offline and online.

ChromaDex’s nicotinamide riboside chloride receives Australia’s TGA ingredient approval

16-Dec-2019 By Guan Yu Lim

ChromaDex has received approval from the Australian Therapeutic Goods Administration (TGA) for use of its patented nicotinamide ribosome chloride (NR) in listed complementary medicines in the country.

Healthy Ageing APAC Summit 2019

Chronological vs biological’: Chromadex aims to use personalised nutrition as means to revolutionise ageing

13-Aug-2019 By Tingmin Koe

Personalised nutrition and other specific therapeutic functions with a focus on changing the concept of ageing are the way forward for ChromaDex’s flagship nicotinamide riboside (NR) supplement, said the firm.

Notes from Nutrition 2018 in Boston

The 'anti-aging' ingredient: Get to know nicotinamide riboside

15-Jun-2018 By Adi Menayang

Brands and suppliers are touting nicotinamide riboside (NR), a form of vitamin B3, as an 'anti-aging' ingredient. What validates it for that use?

Jaksch says move into chairman role part of ChromaDex's pivot toward finished goods

14-May-2018 By Hank Schultz

A strategic pivot toward finished products underpins his impending move toward an advisory role, said ChromaDex CEO Frank Jaksch.

Online opportunities — not loss of big account — drove finished products shift, ChromaDex CEO claims

21-Aug-2017 By Hank Schultz

A shift in market dynamics — not a legal dispute with a key customer — is what drove ChromaDex to try for a second time the finished products route for one of its branded ingredients.